Immune System Disorders
Develop T-Cells from Embryonic Stem Cells
UCLA scientists have for the first time developed immune cells from embryonic stem cells. The discovery could one day improve treatment for people with AIDS and other blood disorders, who lack enough immune cells to fight their disease.
For patients with scleroderma, the prognosis is rarely encouraging. There may now be hope for this group. A study sponsored by the National Institutes of Health shows it may be possible to slow the deterioration caused by the disease.